John Sung Yoo

John Sung Yoo

Director Director DIN 07191074
DIN 07191074 First appointment Jun 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2015
Shareholding value Locked Premium profile

About John Sung Yoo

Data last updated:

John Sung Yoo has 11 years in corporate governance. Formerly with 1 company, such as Takeda Biopharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07191074
Primary Designation Director
First Appointment 11 Jun 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director11 Jun 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Takeda Biopharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for John Sung Yoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Sung Yoo

John Sung Yoo has 11 years in corporate governance. Formerly with 1 company, such as Takeda Biopharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

John Sung Yoo is associated with 0 companies as a director.

John Sung Yoo has expertise in General Business.

John Sung Yoo has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available